TARDBP and amyotrophic lateral sclerosis: As a consequence, mutations in the LCD or other regions of TDP-43 can disrupt these electrostatic interactions, leading to the loss of phase separation and the promotion of abnormal aggregation, which is a central feature in the pathogenesis of ALS and other TDP-43 proteinopathies [64,65].